The basis of IBD treatment is the use of oral drugs based on 5-aminosalicylic acid (5-ASA) with the addition of steroids during an exacerbation of the disease and the transition to tumor necrosis factor inhibitors and immunomodulatory drugs in the absence of remission. Here, TNF is linked to inflammatory bowel disease.